HCA Healthcare, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on October 27, 2025, and October 31, 2025. HCA Healthcare, Inc. (the "Parent Guarantor") and its direct, wholly owned subsidiary, HCA Inc. (the "Issuer"), completed a public offering of senior notes. The filing details the entry into a material definitive agreement and the creation of a direct financial obligation.
Key Financial Metrics and Debt Issuance
The Issuer completed the public offering of $3.25 billion in aggregate principal amount of senior notes, guaranteed on a senior unsecured basis by the Parent Guarantor. The issuance consists of four tranches:
- 2030 Notes: $500 million aggregate principal amount at 4.300% interest, maturing November 15, 2030.
- 2032 Notes: $1.0 billion aggregate principal amount at 4.600% interest, maturing November 15, 2032.
- 2035 Notes: $1.0 billion aggregate principal amount at 4.900% interest, maturing November 15, 2035.
- 2055 Notes: $750 million aggregate principal amount at 5.700% interest, maturing November 15, 2055.
Interest is payable semi-annually on May 15 and November 15, commencing May 15, 2026. The filing does not provide specific data on revenue, profit, cash flow, or existing liquidity metrics; it focuses solely on the new debt issuance.
Material Changes and Terms
The primary material change is the addition of $3.25 billion in new long-term debt obligations. The Notes rank as senior unsecured obligations, equal to existing senior indebtedness but effectively subordinated to secured indebtedness and structurally subordinated to subsidiary liabilities. The underwriting agreement was entered into on October 27, 2025, with J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Mizuho Securities USA LLC, and Wells Fargo Securities, LLC as representatives.
Outlook, Risks, and Covenants
The Indentures include covenants limiting the Issuer's ability to create liens on certain assets, engage in sale and lease-back transactions, and consolidate or merge. A change of control provision allows holders to require repurchase at 101% of the principal amount if a qualifying ratings downgrade and change of control occur. The Notes are subject to optional redemption at prices set forth in the Indentures. No specific forward-looking guidance or management commentary regarding operational outlook is provided in this filing.
Investor Verification Checklist
- Verify the use of proceeds from the $3.25 billion offering in subsequent filings or press releases.
- Confirm the impact of the new debt on the company's leverage ratios and credit ratings.
- Review the specific redemption schedules and call protection periods detailed in the Supplemental Indentures (Exhibits 4.2 through 4.5).
- Monitor for any future ratings downgrades that could trigger the change of control repurchase option.